Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
March 2, 2025
Next generation risk assessment of hair dye HC yellow no. 13: Ensuring protection from liver steatogenic effects
Sara Sepehri, Dinja De Win, Anja Heymans, et al.
Journal of Hepatology
|
May 14, 2021
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Matthias Rombaut, Joost Boeckmans, Robim M Rodrigues, et al.
Pharmacological Research
|
July 3, 2018
Human-based systems: Mechanistic NASH modelling just around the corner?
Joost Boeckmans, Alessandra Natale, Karolien Buyl, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
August 31, 2015
Metabolomics analysis of the toxicity pathways of triphenyl phosphate in HepaRG cells and comparison to oxidative stress mechanisms caused by acetaminophen
Nele Van den Eede, Matthias Cuykx, Robim M Rodrigues, et al.
Archives of Toxicology
|
February 27, 2015
In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells
Robim M Rodrigues, Steven Branson, Veerle De Boe, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
April 3, 2012
Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests
Mounir Bouhifd, Gilles Bories, Juan Casado, et al.
Biomedicines
|
January 21, 2022
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, et al.
Toxicology
|
August 14, 2025
A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals
Anouk Verhoeven, Alexandra Gatzios, Robim M Rodrigues, et al.
Cells
|
December 28, 2019
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Hepatology Communications
|
October 6, 2022
Deletion of adipocyte prohibitin 1 exacerbates high-fat diet-induced steatosis but not liver inflammation and fibrosis
Xiaolin Wang, Seung-Jin Kim, Yukun Guan, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Regulatory Toxicology and Pharmacology : RTP
|
March 2, 2025
Next generation risk assessment of hair dye HC yellow no. 13: Ensuring protection from liver steatogenic effects
Sara Sepehri, Dinja De Win, Anja Heymans, et al.
Journal of Hepatology
|
May 14, 2021
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Matthias Rombaut, Joost Boeckmans, Robim M Rodrigues, et al.
Pharmacological Research
|
July 3, 2018
Human-based systems: Mechanistic NASH modelling just around the corner?
Joost Boeckmans, Alessandra Natale, Karolien Buyl, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
August 31, 2015
Metabolomics analysis of the toxicity pathways of triphenyl phosphate in HepaRG cells and comparison to oxidative stress mechanisms caused by acetaminophen
Nele Van den Eede, Matthias Cuykx, Robim M Rodrigues, et al.
Archives of Toxicology
|
February 27, 2015
In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells
Robim M Rodrigues, Steven Branson, Veerle De Boe, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
April 3, 2012
Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests
Mounir Bouhifd, Gilles Bories, Juan Casado, et al.
Biomedicines
|
January 21, 2022
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, et al.
Toxicology
|
August 14, 2025
A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals
Anouk Verhoeven, Alexandra Gatzios, Robim M Rodrigues, et al.
Cells
|
December 28, 2019
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Hepatology Communications
|
October 6, 2022
Deletion of adipocyte prohibitin 1 exacerbates high-fat diet-induced steatosis but not liver inflammation and fibrosis
Xiaolin Wang, Seung-Jin Kim, Yukun Guan, et al.
Page
of 7